|
PSMD12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.497720E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.068400E-02 |
| Normal-vs-Stage2 |
5.013500E-02 |
| Normal-vs-Stage3 |
4.182000E-04 |
| Normal-vs-Stage4 |
2.00409999999707E-05 |
| Stage1-vs-Stage2 |
9.385000E-01 |
| Stage1-vs-Stage3 |
1.091790E-01 |
| Stage1-vs-Stage4 |
6.140300E-03 |
| Stage2-vs-Stage3 |
2.388200E-01 |
| Stage2-vs-Stage4 |
5.767800E-02 |
| Stage3-vs-Stage4 |
3.411600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.575900E-04 |
| Normal-vs-AfricanAmerican |
2.798400E-01 |
| Normal-vs-Asian |
9.716800E-03 |
| Caucasian-vs-AfricanAmerican |
2.608400E-01 |
| Caucasian-vs-Asian |
9.382600E-01 |
| AfricanAmerican-vs-Asian |
3.482400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.603700E-03 |
| Normal-vs-Female |
2.877900E-03 |
| Male-vs-Female |
4.455000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.546100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.017600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.841250E-03 |
| Normal-vs-Age(81-100Yrs) |
2.702600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.488300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.402200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.673800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.466600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.099600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.712800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.086000E-02 |
| Classical-VS-Follicular |
1.155020E-01 |
| Classical-VS-Other |
2.731600E-01 |
| Classical-VS-Normal |
1.798180E-02 |
| Tall-VS-Follicular |
3.655200E-01 |
| Tall-VS-Other |
9.701000E-01 |
| Tall-VS-Normal |
9.364100E-04 |
| Follicular-VS-Other |
5.930400E-01 |
| Follicular-VS-Normal |
2.502500E-03 |
| Other-VS-Normal |
4.216500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.179900E-04 |
| Normal-vs-N1 |
2.624500E-04 |
| N0-vs-N1 |
4.285200E-01 |
|
|
